Page last updated: 2024-08-26

mafosfamide and Ph 1 Chromosome

mafosfamide has been researched along with Ph 1 Chromosome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almici, C; Carlo-Stella, C; Dotti, GP; Garau, D; Mangoni, L; Piovani, G; Rizzoli, V1
Hegewisch-Becker, S; Hossfeld, DK; Krüger, W; Peters, SO; Stockschläder, M; Weh, HJ; Zander, AR1
Calabretta, B; Christensen, L; Hoser, G; Iozzo, RV; Kawiak, J; Majewski, M; Nieborowska-Skorska, M; Perrotti, D; Skorski, T; Wlodarski, P1

Other Studies

3 other study(ies) available for mafosfamide and Ph 1 Chromosome

ArticleYear
Selection of Philadelphia-negative progenitors from chronic myelogenous leukemia.
    Bone marrow transplantation, 1994, Volume: 14 Suppl 3

    Topics: Antigens, CD; Antigens, CD34; Cell Adhesion; Cell Separation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome

1994
Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Bone marrow transplantation, 1995, Volume: 15, Issue:5

    Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Translocation, Genetic

1995
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Journal of the National Cancer Institute, 1997, Jan-15, Volume: 89, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Marrow; Bone Marrow Cells; Cyclophosphamide; DNA Probes; Flow Cytometry; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, SCID; Oligonucleotides, Antisense; Philadelphia Chromosome; Polymerase Chain Reaction; Survival Analysis; Thionucleotides; Treatment Outcome; Tumor Cells, Cultured

1997